Use of next generation sequencing technologies in research and beyond: Are participants with mental health disorders fully protected?

BMC Medical Ethics (Impact Factor: 1.5). 12/2012; 13(1):36. DOI: 10.1186/1472-6939-13-36
Source: PubMed


Next Generation Sequencing (NGS) is expected to help find the elusive, causative genetic defects associated with Bipolar Disorder (BD). This article identifies the importance of NGS and further analyses the social and ethical implications of this approach when used in research projects studying BD, as well as other psychiatric ailments, with a view to ensuring the protection of research participants.

We performed a systematic review of studies through PubMed, followed by a manual search through the titles and abstracts of original articles, including the reviews, commentaries and letters published in the last five years and dealing with the ethical and social issues raised by NGS technologies and genomics studies of mental disorders, especially BD. A total of 217 studies contributed to identify the themes discussed herein.

The amount of information generated by NGS renders individuals suffering from BD particularly vulnerable, and increases the need for educational support throughout the consent process, and, subsequently, of genetic counselling, when communicating individual research results and incidental findings to them. Our results highlight the importance and difficulty of respecting participants’ autonomy while avoiding any therapeutic misconception. We also analysed the need for specific regulations on the use and communication of incidental findings, as well as the increasing influence of NGS in health care.

Shared efforts on the part of researchers and their institutions, Research Ethics Boards as well as participants’ representatives are needed to delineate a tailored consent process so as to better protect research participants. However, health care professionals involved in BD care and treatment need to first determine the scientific validity and clinical utility of NGS-generated findings, and thereafter their prevention and treatment significance.

Download full-text


Available from: Iris Jaitovich Groisman, Aug 27, 2014
20 Reads
  • Source
    • "A coding scheme was developed based on these themes. Identification of codes was also informed by results of our earlier studies on ethical issues related to the consent process as it applied to the implementation of genomic technologies (Groisman et al. 2012; Mathieu et al. 2013). 1 During a second stage, analysis was expanded to the corresponding institutional IRB guidelines for every case in which thematic data were not coded. The two coders each read and coded 18 IRB guidelines using the same analytical framework. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The potential for next generation sequencing research (NGS) to generate individual genetic results could have implications for the informed consent process and the provision of genetic counseling. We undertook a content analysis of informed consent templates and guidelines produced by Canadian institutional review boards, purposively sampling documents used by researchers to obtain consent from participants in genetics studies. Our goal was to examine the extent to which the informed consent documents addressed genetic counseling and the return of individual genetic results. Our analysis reveals that the majority of informed consent documents did not mention genetic counseling while several did not mention the return of results. We found differences in the ways in which documents addressed availability of counseling, eligibility criteria for referral to a genetic counselor, genetic counselor involvement, provision of services to family members of participants and incidental findings. From an ethical standpoint, consent documents should provide appropriate information so that participants may make an informed decision about their participation in research. The need to ensure adequate counseling for study populations in an NGS research context will necessarily involve adapting values that underlie care in genetic counseling practice. If the interests of research participants are to be truly promoted, the drafting and review of informed consent documents should give proper due to genetic counseling.
    Journal of Genetic Counseling 03/2014; 23(4). DOI:10.1007/s10897-014-9703-x · 2.24 Impact Factor
  • Source
    BMJ (online) 05/2013; 346:f3132. DOI:10.1136/bmj.f3132 · 17.45 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Rapid advances in DNA sequencing technologies have made it increasingly cost effective to obtain accurate and timely large-scale genomic sequence data on individuals (short read massively parallel, or 'next generation' [next-gen]). A next-gen molecular diagnostic approach that has seen rapid deployment in the clinic over the last year is exome sequencing. Whole exome sequencing covers all protein coding genes in the genome (~1.1% of genome) and an exome test for a single patient generates about 6 gigabases (10(9) bp) of DNA sequence data. A key challenge facing routine use of next-gen data in patient diagnosis and management is data interpretation. What sequence variant findings are relevant to diagnosis (pathogenic mutations)? What sequence variant findings are relevant to clinical care, but not necessarily to patient diagnosis (clinically actionable incidental data)? What sequence information should be stored, and where can it be stored? This review provides a tutorial on current approaches to answering these questions. A recent landmark study showed that application of next-gen sequencing to a large cohort of idiopathic dilated cardiomyopathy patients found ~27% of patients to show mutations of the titin gene, the most complex gene in the genome (363 exons). We use titin in cardiomyopathy as an exemplar for explaining next-gen sequencing approaches and data interpretation.
    Circulation Cardiovascular Genetics 07/2013; 6(4). DOI:10.1161/CIRCGENETICS.113.000085 · 4.60 Impact Factor
Show more